PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Drugs in Context1 citationsOpen Access

Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence

View Full Paper
ISI. SchwartzmannARAnna RedondoAFAlba Farré

Key Points

  • This review aims to assess the recent clinical evidence regarding the efficacy and safety of Serenoa repens for treating benign prostatic disorders.
  • Comprehensive systematic review of literature from the past 5 years
  • Includes studies on Serenoa repens used as monotherapy and in combination with other treatments
  • Evidence suggests that Serenoa repens may be effective in reducing symptoms associated with benign prostatic disorders.
  • Safety profile indicates it is well-tolerated with minimal adverse effects.

Abstract

This systematic review comprehensively evaluates literature from the past 5 years on the efficacy and safety of Serenoa repens in the treatment of benign prostatic disorders, either as monotherapy or in combination with other treatments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Schwartzmann et al. (2026) studied this question.

synapsesocial.com/papers/6a095a427880e6d24efe0640https://doi.org/10.7573/dic.2025-10-2
Ask AI
Helpful
Bookmark
Share
View Full Paper